MENLO PARK, Calif., Oct. 26, 2020 /PRNewswire/ -- Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma")...
from PR Newswire: https://ift.tt/35DpPxO
No comments:
Post a Comment